Regulation & law · 03/10/1994

FDA Issues Final Rule on Abbreviated New Drug Application Regulations and Patent Provisions

The US Food and Drug Administration (FDA) has released new regulations governing the submission, review, and approval of abbreviated new drug applications (ANDA's), focusing on patent issues, certification, and exclusivity for new drug products.